AmerisourceBergen Corporation announced Tuesday that it had completed its acquisition of the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses.
AmerisourceBergen purchased the businesses for $6.275 billion in cash, subject to customary working capital and net debt adjustment, and 2 million shares of AmerisourceBergen common stock.
“We are excited to complete the acquisition and extend a warm welcome to the talented team at Alliance Healthcare,” said Steven H. Collis, chairman, president and CEO of AmerisourceBergen. “The acquisition of Alliance Healthcare expands our reach and solutions in pharmaceutical distribution and adds to AmerisourceBergen’s breadth and depth of global manufacturer services. With Alliance Healthcare, we will advance our ability to provide innovative and global healthcare solutions and further our purpose of being united in our responsibility to create healthier futures.”
AmerisourceBergen said it anticipates revenue to climb to at least $210 billion, up from $200 billion. As a result, the adjusted diluted earnings per share would be in the range of $8.90 to $9.10, up from $8.45 to $8.60.
“This transaction provides great benefit for both companies and is a logical step following the continued success of our long-term strategic relationship,” said Ornella Barra, Chief Operating Officer, International, Walgreens Boots Alliance, Inc. “The Alliance Healthcare teams are joining a global pharmaceutical distribution leader and trusted partner in AmerisourceBergen, and we look forward to continuing to work together as strategic partners.”
The companies said they will also execute on expanding and extending commercial agreements to drive incremental growth and synergies.